Selecting a Serotonin Reuptake Inhibitor for Obsessive-Compulsive Disorder

CNS Spectrums

Volumn 1, Issue 2, 1996, Pages 32-38

  Kelly, Alison ^a  

^a AMERSHAM HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0343483765     PISSN: 10928529     EISSN: 21656509     Source Type: Journal    
DOI: 10.1017/S1092852900002625     Document Type: Article

References (48)

1. Black, A. The natural history of obsessional neurosis. In: Beech, HR, ed. Obsessional States. London: Methuen & Co; 1974.
2. Karno, M, Golding, J, Sorenson, S, Burnham, MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988; 45: 1094–1099.
3. Hollander, E, Fay, M, Cohen, B, et al, Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioural findings. Am J Psychiatry. 1988; 145: 1015–1017.
4. Zohar, J, Meuller, EA, Insel, TR, et al, Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry. 1987; 44: 946–951.
5. Bastani, B, Nash, JF, Meltzer, HY. Prolactin and cortisol responses to MK212, a serotonin agonist in obsessive compulsive disorder. Arch Gen Psychiatry. 1990; 47: 833–837.
6. Insel, TR, Mueller, EA, Alterman, I. Pathogenesis of obsessive compulsive disorder and serotonin: is there a connection? Biol Psychiatry. 1985; 20: 1174–1188.
7. Thoren, P, Asberg, M, Cronholm, B, Jornestedt, L, Traskman, L. Clomipramine treatment of obsessive-compulsive disorder: a controlled clinical trial. Arch Gen Psychiatry. 1980; 37: 1281–1285.
8. Ananth, J, Pecknold, JC, van den Steen, N, Engelsmann F. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Prog Neuropsychopharmacol. 1981; 5: 257–262.
9. Volavka, J, Neziroglu, F. Yarayura-Tobias, JA. Clomipramine and imipramine in obsessive compulsive disorder. Psychiat Res. 1985; 14: 83–91.
10. Leonard, HL, Swedo, SE, Rapoport, JL, et al, Treatment of obsessive compulsive disorder with clomipramine and desipramine in children and adolescents. Arch Gen Psychiatry. 1989; 46: 1088–1092.
11. Ananth, J, Pecknold, JC, Van Der Steen, N, et al, Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Prog Neuropsychopharmacoi. 1981; 5: 257–262.
12. DeVeaugh-Geiss, J, Landau, P, Katz, R. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder. Psychopharmacol Bull. 1989; 25: 36–40.
13. Jenike, MA, Baer, L, Summergrad, P, Weilburg, JB, Holland, A, Seymour, R. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients. Am J Psychiatry. 1989; 146: 1328–1330.
14. Katz, RJ, Landau, P, DeVeaugh-Geiss, J, Hakkarainen, H. Therapeutic effects of anafranil in obsessive compulsive disorder. Recent clinical findings. Prog Clin Biol Res. 1990: 361: 489–493.
15. Greist, JH, Jefferson, JW, Rosenfeld, R. Gutzmann, LD, March, JS, Barklage, NE. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients. J CM Psychiatry. 1990; 51: 292–297.
16. The Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1991; 48: 730–738.
17. Pato, MT, Pigott, TA, Hill, JL, Grover, GN, Bernstein, S, Murphy, DL. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder. Am J Psychiatry. 1991; 148: 127–129.
18. Hewlett, WA, Vinogradov, S, Agras, WS. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder. J CM Psychopharmacol. 1992: 12: 420–430.
19. Vallejo, J, Olivares, J, Marcos, T, Bulbena, A, Menchon, JM. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. Br J Psychiatry. 1992; 161: 665–670.
20. Perse, TL, Greist, JH, Jefferson, JW, Rosenfeld, R, Dar, R. Fluvoxamine treatment of obsessive-compulsive disorder. Am J Psychiatry. 1987; 144: 1543–1548.
21. Goodman, WK, Price, LH, Rasmussen, SA, Delgado, PL, Heninger, GR, Charney, DS. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry. 1989; 46: 36–44.
22. Jenike, MA, Hyman, S, Baer, L, et al, A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Am J Psychiatry. 1990; 48: 1415–1416.
23. Mallaya, GK, White, K, Waternaux, G, Quay, S. Short- and long-term treatment of obsessive compulsive disorder. Ann CM Psychiatry. 1992; 4: 77–80.
24. Greist, JH, Jenike, MA, Robinson, D, Rasmussen, SA. Efficacy of fluvoxamine in obsessive-compulsive disorder: results of a multicentre, double-blind, placebo-controlled trial. Eur J Clin Res. 1995; 7: 195–204.
25. Goodman, WK, Kozak, MJ, Liebowitz, M, White, KL. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial. Int Clin Psychopharmacol In press.
26. Smeraldi, E, Erzegovesi, S, Bianchi, I, Pasquali, L, Cocchi, S, Ronchi, P. Fluvoxamine vs clomipramine treatment in obsessive compulsive disorder: a preliminary study. New Trends Exp Clin Psychiatry. 1992; 8: 63–65.
27. Freeman, CP, Trimble, MR, Deakin, JF, Stokes, TM, Ashford, JJ. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel-group comparison. J Clin Psychiatry. 1994; 55: 301–305.
28. Yargic, LI, Enderer, M, Imre, H, Sen, D, Yazici, O. A randomized, single-blind comparison of clomipramine and fluvoxamine in OCD patients. Nowpsikiyatr Ars. 1995; 32: 70–75.
29. Koran, LM, McElroy, SL, Davidson, JRT, Rasmussen, SA, Hollander, E, Jenike, MA. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. J Clin Psychopharmacol. In press.
30. Goodman, WK, Price, LH, Delgado, PL, et al, Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry. 1990; 48: 483–484.
31. Pigott, TA, Pato, MT, Bernstein, SE, et al, Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioural and biological results. Arch Gen Psychiatry. 1990; 47: 926–932.
32. Ananth, J, Elmishad, A, Wohl, M. Clomipramine vs fluoxetine in obsessive compulsive disorder: an uncontrolled study. Adv Ther. 1993; 10: 288–292.
33. Montgomery, SA, McLntyre, A, Osterheider, M, et al, for The Lilly European OCD Study Group. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-IIl-R obsessive-compulsive disorder. Eur Neuropsychopharmacol. 1993; 3: 143–152.
34. Tollefson, GD, Rampey, AH, Potvin, JH, et al, A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive compulsive disorder. Arch Gen Psychiatry. 1994; 51: 559–567.
35. Chouinard, G, Goodman, W, Greist, J, et al, Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull. 1990; 26: 279–284.
36. Greist, JH, Jefferson, JW, Kobak, KA, et al, A 1-year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol. 1995; 10: 57–65.
37. Jenike, MA, Baer, L, Summergrad, P, Minichiello, WE, Holland, A, Seymour, R. Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo. Am J Psychiatry. 1990; 147: 923–928.
38. Kaye, NS, Dancu, C. Paroxetine and obsessive-compulsive disorder. Am J Psychiatry. 1994; 151: 1523.
39. Goodman, WK, Steiner, M, Bushnell, W, et al, Efficacy of fixed doses of paroxetine in the treatment of obsessive-compulsive disorder: a randomized double-blind trial. J Clin Psychopharmacology. In press.
40. Hollander, E, Wong, CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry. 1995; 56(suppl 4):3–6.
41. Phillips, KA, McElroy, SL, Hudson, JI, Pope, HG Jr. Body dysmorphic disorder: an obsessive-compulsive spectrum dis-order, a form of affective spectrum disorder, or both? J Clin Psychiatry. 1995; 56 (suppl 4):41–52.
42. Hollander, E, Wong, CM. Body dysmorphic disorder, patho-logical gambling, and sexual compulsions. J CM Psychiatry. 1995; 56;(suppl 4):7–13.
43. Flament, MF, Whitaker, A, Rapaport, JL. Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry. 1988; 27: 764–771.
44. Apter, A, Ratzioni, G, King, R. Fluvoxamine open label treatment of adolescent in-patients with obsessive compulsive disorder or depression. J Am Acad Child Adolesc Psychiatry. 1994; 33: 342–348.
45. Riddle, MA, Hardin, MT, King, R, Scahill, L, Woolston, JL. Fluoxetine treatment of obsessions and compulsions in patients with Tourette's syndrome. Am J Psychiatry. 1988; 145: 1173–1174.
46. Dominguez, RA, Mestre, SM. Management of treatment-refractory obsessive compulsive disorder patients. J Clin Psychiatry. 1994; 55: (suppl 10):86–92.
47. Van Balkom, AJLM, Van Oppen, P, Vermeulen, AWA, Van Dyck, R, Nauta, MCE, Vorst, HCM. A meta-analysis on the treatment of obsessive compulsive disorder: a comparison of antidepressants, behavior, and cognitive therapy. Clin Psychol Rev. 1994; 14: 359–381.
48. Stein, DJ, Spadaccini, E, Hollander, E. Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. Int Clin Psychopharmacol. 1995; 10: 11–18.